Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT02942043 · UNKNOWN
Trial details
- NCT number
- NCT02942043
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-05-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.